Randomized Controlled Trial

Randomized Controlled Trial of Conventional Versus MicroNet^TM-Covered Stent in Carotid Artery Revascularization

Objective: The aim of this study was to compare procedure-related ipsilateral cerebral embolism with a conventional (Acculink, Abbott Vascular) versus a MicroNet^TM-covered (CGuard^TM, InspireMD) stent in carotid artery stenting (CAS).

Conclusion: The MicroNet^TM-covered stent significantly reduced periprocedural and abolished postprocedural cerebral embolism compared to a conventional carotid stent. This is consistent with the MicroNet^TM-covered stent’s sustained embolism prevention, which translates into cerebral protection during and after CAS. The present findings may influence decision-making in carotid revascularization.